Physician

Philip G Barton, M.D.

According to 2025 Medicare claims, Philip Barton, M.D. (NPI: 1174526891) practices dermatology in the Ocala, FL market, with the plurality of this provider's patient population coming from Marion, FL. This provider's primary affiliated billing organization is OCALA DERMATOLOGY & SKIN CANCER CENTER, P.A. (NPI: 1871599365; TIN: 593238249) and primary practice location at 34491-8970.

Barton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,029 traditional Medicare patients, billed 13,924 HCPCS/CPT codes, and received $909,657 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,476 prescription claims across 634 beneficiaries totaling $443,311 in drug costs, led by Tacrolimus (Tacrolimus). Open Payments data shows 14 records totaling $378. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $118,183 to $443,311. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,155	14,309	$680,146
2016	2,373	15,735	$753,926
2017	2,236	13,899	$680,413
2018	2,218	14,011	$709,843
2019	2,253	14,018	$719,562
2020	2,369	12,836	$655,065
2021	2,451	14,480	$702,043
2022	2,388	15,052	$838,629
2023	2,094	13,206	$764,437
2024	2,029	13,924	$909,657

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	420	864	$118,183
2016	531	1,101	$151,647
2017	508	1,068	$231,889
2018	528	1,129	$157,725
2019	579	1,343	$173,748
2020	575	1,299	$189,546
2021	650	1,399	$206,627
2022	604	1,295	$237,406
2023	561	1,196	$290,117
2024	634	1,476	$443,311

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	639	776	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,113	1,378	$66
11102	Biopsy of related skin growth, first growth	707	887	$62
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	967	1,183	$38
17000	Destruction of precancer skin growth, 1 growth	897	1,260	$36

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tacrolimus	Tacrolimus	13	675	$3,372
Gentamicin Sulfate	Gentamicin Sulfate	126	2,794	$2,861
Acitretin	Acitretin	18	806	$2,574
Metronidazole	Metronidazole	36	1,220	$2,555
Ketoconazole	Ketoconazole	143	4,283	$2,001

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$378	SUN PHARMACEUTICAL INDUSTRIES INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Philip G. Barton, M.D.?

Tedicare shows public-source Medicare data for Philip G. Barton, M.D. (NPI 1174526891), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Philip G. Barton, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Philip G. Barton, M.D.?

Philip G. Barton, M.D. is linked to OCALA DERMATOLOGY & SKIN CANCER CENTER, P.A. (billing NPI 1871599365) in the available physician profile data.

Does Philip G. Barton, M.D. have Open Payments data?

Philip G. Barton, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.